Chronic lymphocytic leukemia therapy: new targeted therapies on the way

Por Vitale, Candida, Burger, Jan A
Publicado no Expert Opin Pharmacother (2016)

t(9;22) as secondary alteration in core-binding factor de novo acute myeloid leukemia

Por Vitale, Candida, Lu, Xinyan, Abderrahman, Balkees, Takahashi, Koichi, Ravandi, Farhad, Jabbour, Elias
Publicado no Am J Hematol (2015)

Letter to the Editor: A Phase II study of the combination of rituximab and granulocyte macrophage colony stimulating factor as treatment of patients with chronic lymphocytic leukem...

Por Strati, Paolo, Tong, Wei-Gang, Vitale, Candida, Wierda, William G, O’Brien, Susan, Brown, Jennifer R, Weng, Wen-Kai, Kipps, Thomas, Keating, Michael J., Ferrajoli, Alessandra
Publicado no Leuk Lymphoma (2014)

Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma

Por Castella, Barbara, Foglietta, Myriam, Sciancalepore, Patrizia, Rigoni, Micol, Coscia, Marta, Griggio, Valentina, Vitale, Candida, Ferracini, Riccardo, Saraci, Elona, Omedé, Paola, Riganti, Chiara, Palumbo, Antonio, Boccadoro, Mario, Massaia, Massimo
Publicado no Oncoimmunology (2015)

Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells

Por Rigoni, Micol, Riganti, Chiara, Vitale, Candida, Griggio, Valentina, Campia, Ivana, Robino, Marta, Foglietta, Myriam, Castella, Barbara, Sciancalepore, Patrizia, Buondonno, Ilaria, Drandi, Daniela, Ladetto, Marco, Boccadoro, Mario, Massaia, Massimo, Coscia, Marta
Publicado no Oncotarget (2015)

Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib

Por Vitale, Candida, Ahn, Inhye E., Sivina, Mariela, Ferrajoli, Alessandra, Wierda, William G., Estrov, Zeev, Konoplev, Sergej N., Jain, Nitin, O’Brien, Susan, Farooqui, Mohammed, Keating, Michael J., Wiestner, Adrian, Burger, Jan A.
Publicado no Haematologica (2016)

Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia

Por Griggio, Valentina, Mandili, Giorgia, Vitale, Candida, Capello, Michela, Macor, Paolo, Serra, Sara, Castella, Barbara, Peola, Silvia, Foglietta, Myriam, Drandi, Daniela, Omed, Paolaé, Sblattero, Daniele, Cappello, Paola, Chiarle, Roberto, Deaglio, Silvia, Boccadoro, Mario, Novelli, Francesco, Massaia, Massimo, Coscia, Marta
Publicado no Oncotarget (2016)

Ofatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation between Responses and Immune Characteristics

Por Vitale, Candida, Falchi, Lorenzo, ten Hacken, Elisa, Gao, Hui, Shaim, Hila, Van Roosbroeck, Katrien, Calin, George, O'Brien, Susan, Faderl, Stefan, Wang, Xuemei, Wierda, William G., Rezvani, Katayoun, Reuben, James M., Burger, Jan A., Keating, Michael J., Ferrajoli, Alessandra
Publicado no Clin Cancer Res (2016)